Veradermics, Incorporated

US$138.78As of Sun 8 Nov 2026, 12:00 UTC
NYSE:MANEHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$5.798B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$150
8.30%
(63.33%)
Hold 10|7|1|5|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.52
1.51
1.59
1.56
16.78%
8.10%
6.88%
7.59%
Revenue$M
394.1
401.4
399.3
391.1
7.62%
5.68%
1.83%
1.49%
Peers (US$5.798B)
Cap (US$)
PE
5.900B
13.54x
Capital
TTM
5Y
10Y
Leveragex
1.223
0.153
0.131
EBIT/Intx
0.297
0.804
1.055
Own earn%
(131.20)
97.89
96.50
Sh yield%
36.35
42.40
42.14
Owners
Insiders/Inst%
4.44
53.91
Short interest%
0.60
SBC / revenue%
1.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
10–18
$1 testx
−0.3
Incr. ROIC%
0